AI Translates Nature into New Medicines | StartUp Health Insights: Week of Nov 26, 2024
Big investments in AI, virtual care, and next-generation diagnostics highlight a vibrant health innovation landscape. From children’s health to streamlining medication journeys, this week's funding paints a promising picture for the future of healthcare.
This week’s reported health innovation funding included:
Enveda, a Boulder, CO-based biotechnology company using AI to translate nature into new medicines, raised $130M led by Kinnevik and FPV, with participation from Baillie Gifford, Premji Invest, Lingotto Innovation, Lux Capital, Dimension Capital, True Ventures, Cresset Partners, The Nature Conservancy, and Henry R. Kravis. <source>
Ladder, a Austin, TX-based virtual strength training startup, raised $105M from General Catalyst's Customer Value program, Point72 Ventures, ADvantage VC, PagsGroup, Tapestry VC, and LivWell Ventures. <source>
Cortica, a San Diego, CA-based care provider for children with autism and neurodivergent conditions, raised $80M co-led by Morgan Health and Nexus NeuroTech Ventures, with participation from Autism Impact Fund. <source>
Ōura, an Oulu, Finland-based developer of a smart ring for health tracking, raised $75M from Dexcom. <source>
TailorMed, a New York, NY-based healthcare tech company building an end-to-end platform designed to eliminate barriers along the entire medication journey, raised $40M led by Windham Capital Partners, with participation from Citi Impact Fund, Samsung Next, BrightEdge, Providence Ventures, OSF Healthcare, Inception Health, Ballad Ventures, UH Ventures, UnityPoint Health Ventures, Sanara Ventures, Triventures, Accelmed, Almeda Ventures, and Bridges. Debt facility was led by Poalim-tech, part of Israel’s leading bank, Bank HaPoalim. <source>
Zarminali Health, a Chicago, IL-based pediatric health startup, raised $40M from General Catalyst. <source>
Synapticure, a Chicago, IL-based virtual care company dedicated to improving access and outcomes for patients and caregivers living with neurodegenerative diseases, raised $25M led by B Capital, with participation from CommonSpirit Health, CVS Health Ventures, RA Capital Management, Nexus NeuroTech Ventures, Google Ventures, Optum Ventures, and Rock Health Capital. <source>
New Lantern, a San Francisco, CA-based cloud-native AI radiology suite company, raised $19M led by Benchmark, with participation from Afore Capital, Anthology Fund, Neo, SV Angel, Guillermo Rauch, Amjad Masad, Saji Wickramasekara, Jay Kreps, and Gokul Rajaram, and other investors. <source>
OneCell Diagnostics, a Cupertino, CA- and Mumbai, India-based genomics-based precision oncology company, raised $16M led by Celesta Capital, with participation from Tenacity Ventures, Cedars Sinai, Eragon, and Singularity Ventures. <source>
World Class Health, a New York, NY-based concierge health benefit for employers, raised $8M led by AlleyCorp, with participation from LifeX, Joyance, Cooley & Co, City Light, and individual investors. <source>
CalmWave, a Seattle, WA-based creator of the Quiet ICU designed to optimize hospital operations, raised $5.25M led by Third Prime, with participation from Catalyst by Wellstar, Silver Circle, Rebellion, Impulsum, Bonfire Ventures, Tau Ventures, and Hike Ventures. <source>
MAGIC AI, a London, UK-based provider of an AI-powered fitness mirror, raised $5M from Baleen Capital, SFC Capital and Ventures, and individual investors. <source>
ThoroughCare, a Pittsburgh, PA-based company that specializes in care coordination solutions, raised $5M led by Empactful Capital. <source>
Cofactor AI, a Chicago, IL-based AI-powered platform for hospitals, raised $4M led by Drive Capital. <source>
DANNCE.AI, a Boston, MA-based company providing clinicians and drug developers a digital phenotyping platform, raised $2.6M led by LDV Capital, with participation from Glasswing Ventures, The Leo Lion Company, Duke Capital Partners, and Merck Digital Sciences Studio. <source>
OncoVerity, an Aurora, CO-based company that specializes in applying advanced bioinformatics to drug development, raised an undisclosed Series A extension led by argenx and RefinedScience. <source>
Data is from StartUp Health Insights, the most comprehensive funding database for health innovation. Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.
Call for Innovation
Are You Ready to Find Your Tribe?
We’re looking for founders and CEOs leading digital health, life science, or biotech companies that are solving the biggest health challenges of our time – and want to build a better network to change the world. Our communities include: Access to Care, Addiction & Opioid Crisis, Alzheimer’s Disease, Cardiometabolic Health, Children’s Health, End Cancer, Food as Medicine, Healthy Longevity, Maternal Health, Men’s Health, Mental Health, Oral Health, Rare Diseases, Respiratory Health, Type 1 Diabetes, Wellness, Women's Health, and more.
If you’re mission-driven, collaborative, and ready to contribute as much as you gain, you might be the perfect fit. Learn more and apply today.
Follow us on social media for daily updates on Health Transformers: X (Twitter), LinkedIn, Facebook, and Instagram.